Ignite Creation Date:
2024-05-05 @ 12:11 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00266721
Status:
COMPLETED
Last Update Posted:
2005-12-19
First Post:
2005-12-15
Brief Title:
Efficacy of Pancrelipase on Postprandial Belching and Bloating
Sponsor:
Solvay Pharmaceuticals
Organization:
Minneapolis Veterans Affairs Medical Center
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2000-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The hypothesis of this study is that the administration of pancrelipase with meals will benefit symptoms of post-prandial bloating pain and eructation
Detailed Description:
Subjects will complete a double-blind crossover study in which for one week periods they will receive two pancrelipase tablets with each of the three major meals or a similarly administered identical placebo Three times daily subjects will rate the severity of belching epigastric discomfort epigastric fullness bloating and nausea
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None